SIRT3 and glioblastoma: In the GBM cell line U251 and GBM#4 cells, reductions in SIRT3 expression and activity, respectively, upon treatment with shRNA and 3-TYP, individually, were confirmed by Western blotting analysis of the pan-acetylation level of mitochondrial proteins (Fig. 4A, F).